Literature DB >> 17036946

Syringocystadenoma papilliferum: report of 8 cases.

S Rammeh-Rommani1, B Fezaa, E Chelbi, M R Kammoun, S Baltagi Ben Jilani, R Zermani.   

Abstract

Syringocystadenoma papilliferum (SCAP) is a rare cutaneous adnexal neoplasm with variable clinical appearance and characteristic histology. It arises in about one third of cases within a sebaceous hamartoma (SH) and in this case, multiple other benign adnexal neoplasms may be associated with it. We report the clinical and pathological data of 8 cases of syringocystadenoma papilliferum. The age at the time of the diagnosis varied from 3 to 48 years with an average age of 28 years. Three tumors were localized in the scalp, 2 in the trunk, and 3 others of unusual locations: 1 in the eyelid, 1 in the thigh and 1 in the popliteal fossa. Histopathological examination revealed 3 SCAP occurring within SH. The SCAP observed in the eyelid was associated with an apocrine cystadenoma without features of SH. The four others were not associated with any other lesion.

Entities:  

Mesh:

Year:  2006        PMID: 17036946

Source DB:  PubMed          Journal:  Pathologica        ISSN: 0031-2983


  4 in total

1.  Syringocystadenoma papilliferum: an unusual presentation.

Authors:  Ranjan Agrawal; Parbodh Kumar; Rahul Varshney
Journal:  J Clin Diagn Res       Date:  2014-05-15

2.  A case of syringocystadenoma papilliferum on lower leg: a rare location.

Authors:  Vinod K Khurana; Raj K Mehta; Deepak Chaudhary; Leela Pant
Journal:  Indian J Dermatol       Date:  2013-09       Impact factor: 1.494

3.  Tubulopapillary hidradenoma: A rare case with cytohistopathological correlation.

Authors:  Neha Kawatra Madan; Shilpi Agarwal; Manupriya Nain
Journal:  J Cytol       Date:  2013-04       Impact factor: 1.000

4.  Syringocystadenoma papilliferum in the right lower abdomen: a case report and review of literature.

Authors:  Dong Xu; Tienan Bi; Huanrong Lan; Wenjie Yu; Wenmin Wang; Feilin Cao; Ketao Jin
Journal:  Onco Targets Ther       Date:  2013-03-26       Impact factor: 4.147

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.